148 related articles for article (PubMed ID: 20575692)
21. CCND1 G870A polymorphism contributes to breast cancer susceptibility: a meta-analysis.
Lu C; Dong J; Ma H; Jin G; Hu Z; Peng Y; Guo X; Wang X; Shen H
Breast Cancer Res Treat; 2009 Aug; 116(3):571-5. PubMed ID: 18819000
[TBL] [Abstract][Full Text] [Related]
22. Association between
Thakur N; Kumari S; Mehrotra R
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30361291
[No Abstract] [Full Text] [Related]
23. Association between cyclin D1 G870A polymorphism and cervical cancer risk: a cumulative meta-analysis involving 2,864 patients and 3,898 controls.
Hu YY; Zheng R; Guo C; Niu YM
Diagn Pathol; 2014 Sep; 9():168. PubMed ID: 25204741
[TBL] [Abstract][Full Text] [Related]
24. The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis.
Tan XL; Nieters A; Kropp S; Hoffmeister M; Brenner H; Chang-Claude J
Int J Cancer; 2008 Jun; 122(11):2573-80. PubMed ID: 18196581
[TBL] [Abstract][Full Text] [Related]
25. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS
J BUON; 2013; 18(1):227-38. PubMed ID: 23613410
[TBL] [Abstract][Full Text] [Related]
26. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study.
Zheng Y; Shen H; Sturgis EM; Wang LE; Eicher SA; Strom SS; Frazier ML; Spitz MR; Wei Q
Carcinogenesis; 2001 Aug; 22(8):1195-9. PubMed ID: 11470749
[TBL] [Abstract][Full Text] [Related]
27. CCND1 G870A polymorphism is associated with toxicity of methotrexate in childhood acute lymphoblastic leukemia.
Xue Y; Rong L; Tong N; Wang M; Zhang Z; Fang Y
Int J Clin Exp Pathol; 2015; 8(9):11594-600. PubMed ID: 26617896
[TBL] [Abstract][Full Text] [Related]
28. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
[TBL] [Abstract][Full Text] [Related]
29. Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer.
Ito M; Habuchi T; Watanabe J; Higashi S; Nishiyama H; Wang L; Tsuchiya N; Kamoto T; Ogawa O
Urology; 2004 Jul; 64(1):74-8. PubMed ID: 15245939
[TBL] [Abstract][Full Text] [Related]
30. Cyclin D1 G870A polymorphism is a risk factor for esophageal cancer among Asians.
Zhuo W; Zhang L; Wang Y; Zhu B; Chen Z
Cancer Invest; 2012 Nov; 30(9):630-6. PubMed ID: 23020291
[TBL] [Abstract][Full Text] [Related]
31. Cyclin D1 polymorphism and the risk of endometrial cancer.
Kang S; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Gynecol Oncol; 2005 May; 97(2):431-5. PubMed ID: 15863141
[TBL] [Abstract][Full Text] [Related]
32. Cyclin D1 (CCND1) G870A polymorphisms and cervical cancer susceptibility: a meta-analysis based on ten case-control studies.
Wu Y; Fu H; Zhang H; Huang H; Chen M; Zhang L; Yang H; Qin D
Tumour Biol; 2014 Jul; 35(7):6913-8. PubMed ID: 24737585
[TBL] [Abstract][Full Text] [Related]
33. Association between cyclin D1 (CCND1) polymorphism and gastric cancer risk in Japanese population.
Tahara T; Arisawa T; Shibata T; Yamashita H; Hirata I
Hepatogastroenterology; 2009; 56(93):1232-5. PubMed ID: 19760977
[TBL] [Abstract][Full Text] [Related]
34. Functional role of CyclinD1 polymorphism (G870A) in modifying susceptibility and overall survival of North Indian lung cancer patients.
Pandey A; Bahl C; Sharma S; Singh N; Behera D
Tumori; 2018 Jun; 104(3):179-187. PubMed ID: 30086699
[TBL] [Abstract][Full Text] [Related]
35. Cyclin D1 Pro241Pro (CCND1-G870A) polymorphism is associated with increased cancer risk in human populations: a meta-analysis.
Pabalan N; Bapat B; Sung L; Jarjanazi H; Francisco-Pabalan O; Ozcelik H
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2773-81. PubMed ID: 18843022
[TBL] [Abstract][Full Text] [Related]
36. GG genotype of cyclin D1 G870A polymorphism is associated with non-cardiac gastric cancer in a high-risk region of China.
Jia A; Gong J; Li Y; Hao Z; Chang X; Dai F; Yu B
Scand J Gastroenterol; 2008; 43(11):1353-9. PubMed ID: 18609126
[TBL] [Abstract][Full Text] [Related]
37. Cyclin D1 G870A polymorphism is associated with an increased risk of multiple myeloma.
Wang S; Huang Y; Su R; Fang Z; Han M
Genet Mol Res; 2015 Jun; 14(2):5856-61. PubMed ID: 26125784
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer and cyclin D1 gene polymorphism in Turkish women.
Yaylim-Eraltan I; Ergen A; Görmüs U; Arikan S; Küçücük S; Sahin O; Yigit N; Yildiz Y; Isbir T
In Vivo; 2009; 23(5):767-72. PubMed ID: 19779113
[TBL] [Abstract][Full Text] [Related]
39. Effect of cyclin D1 (CCND1) polymorphism on gastric premalignant condition.
Tahara T; Shibata T; Yamashita H; Hirata I; Arisawa T
Clin Chem Lab Med; 2008; 46(12):1696-701. PubMed ID: 19055446
[TBL] [Abstract][Full Text] [Related]
40. A cyclin D1 (CCND1) gene polymorphism contributes to susceptibility to papillary thyroid cancer in the Turkish population.
Aytekin T; Aytekin A; Maralcan G; Gokalp MA; Ozen D; Borazan E; Yilmaz L
Asian Pac J Cancer Prev; 2014; 15(17):7181-5. PubMed ID: 25227811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
